Funding for this research was provided by:
Text and Data Mining valid from 2018-06-05
Received: 27 October 2017
Accepted: 13 April 2018
First Online: 5 June 2018
Ethics approval and consent to participate
: The study received approval of the medical ethical commission (Medisch Ethische Toetsingscommissie) and was classified under the protocol number 15-444/C approved on 29th July 2015.
: Peter R Seevinck declares to be a majority shareholder of MRIGuidance B.V. Cornelis A T van den Berg declares to be a minority shareholder of MRCode B.V.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.